PharmaVOICE - 
April 2013
Purchase Issue

In Every Issue
Last Word
Changing Healthcare Landscape Requires a New Listening Role Nicole Black, [...]
By

Nicole Black, Director of Customer Experience, Janssen Biotech

Talent Pool
Pharma Pool Dr. John REED Roche Corporate Executive Committee Appoints [...]
By

Ann Grey

On the Calendar
The Calendar The Healthcare Businesswomen’s Association’s 24th Woman of the [...]
By

Heather Hummel

PharmaTrax
Companion Diagnostics Key to Personalized Medicines Trending now: Companion diagnostics [...]
By

Denise Myshko

Tools of the Trade
TGaS Launches Partnering Tool Trending Now: New tool allows companies [...]
By

Denise Myshko

What’s New
What’s New The clinical research organization, PharmaNet/i3, has been renamed [...]
By

Ann Grey

Marketing Tips & Techniques
Marketing Tips & Techniques: Measuring ROI Trending Now: More than [...]
By

Robin Robinson

UpFront
» Lilly Recognized for Fifth Straight Year by NAFE Lilly [...]
By

Denise Myshko

Letter from the Editor
The forum for the industry executive Volume 13 • Number [...]
By

Taren Grom, Editor

On The Cover

Empowered Patients
Even before treatment and disease state information became so abundantly available online, empowered patients had begun to take the reins of their own healthcare education, searching for information that would equip them to make better decisions toward improved healthcare outcomes. Today, more than ever, the empowered patient is shaping the way healthcare — and healthcare [...]
By

Robin Robinson

Features

Medical Affairs: The Catalyst for Effective Medical Communications
It has been said knowledge is power. Throughout the ages, healthcare professionals have been revered as powerful not only for their medical acumen but for the ability to heal the sick. Today as therapeutic options become more complex, physicians need to continually update and expand their knowledge base to stay current and provide the best [...]
By

Debra Joyce, Senior VP, Managing Director, SCI Scientific Communications & Information, part of Ogilvy CommonHealth Worldwide

SHOWCASE FEATURE: Medical Affairs: Beyond the Science
Beyond the Science By Taren Grom Medical affairs professionals are integral to creating new bridges that cross internal departments and connect to new stakeholders to share the increasing amount of scientific information available. With the current healthcare system requiring more data, quality evidence, and proof of quality of care from manufacturers in increasing numbers, pharma [...]
By

Taren Grom, Editor

C-Suite: CROs
CROs: Integrated Outsourcing Growth Opportunities Ahead The global R&D outsourcing market by 2018 is expected to be 37.1% of the total pharmaceutical R&D expenditure compared with 25.3% in 2010. In GBI Research’s latest report, Contract Research Organizations (CROs) Market to 2018 — Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs, analysts say [...]
By

Taren Grom, Editor

Singapore’s Strong Economy Creates Pharma Opportunity
Singapore’s Strong Economy Creates Pharma Opportunity With its developed world economy and strong government support for innovation and business, Singapore offers a healthy environment for life-sciences companies to conduct research, development, and manufacturing. By Kim Ribbink Singapore is a South-East Asian island nation with a population of around 5 million people. The country enjoys a [...]
By

Kim Ribbink

Evolving Regulations in mHealth
Evolving Regulations in mHealth Regulators are still working to understand mobile health applications. As a result, unclear guidance is creating a challenge for pharmaceutical companies. By Denise Myshko Mobile devices have already changed the way we live and work. Now smartphones and other mobile devices are poised to transform healthcare. Global trends in healthcare are [...]
By

Denise Myshko

Cracking Down on Fake Drugs
Cracking Down on Fake Drugs The fight to protect the pharmaceutical supply chain is a global one, requiring law enforcement, regulatory agencies, and companies to come together for the health of patients. Counterfeit goods are big business. But when it comes to counterfeit medicines, it’s a public health issue as well. Counterfeit prescription medicines have [...]
By

Denise Myshko

The Highs and Lows of Social Media
Pharma has made great strides in its digital marketing efforts, but many companies are still hesitant to walk the social media path. The lack of regulatory guidance is a major deterrent, according to a recent Cutting Edge Information report. Although the FDA provided some guidance in terms of social media in December 2011, the context [...]
By

Robin Robinson

FEEDBACK